科拓生物：KEX02活菌胶囊联合PD-1抑制剂治疗非小细胞肺癌的药物管线临床研究项目处于Ⅰ期临床阶段

Group 1 - The company is advancing its clinical research on KEX02 probiotic capsules in combination with PD-1 inhibitors for the treatment of non-small cell lung cancer, currently in Phase I clinical stage [2] - The collaboration is with Shenzhen Unknown Jun Biotechnology Co., Ltd., indicating a partnership in the development of this innovative drug pipeline [2] - The company will provide timely updates on the progress of the project as it develops [2]